AOTI, Inc. ( (GB:AOTI) ) has issued an announcement.
AOTI, Inc. announced that its CEO, Dr. Mike Griffiths, and CFO, Jayesh Pankhania, will present the company’s preliminary results via a live session on Investor Meet Company on April 28, 2025. The presentation is accessible to current and potential shareholders, allowing them to submit questions beforehand or during the event. This initiative underscores AOTI’s commitment to transparency and engagement with its stakeholders, potentially enhancing its market position and investor relations.
More about AOTI, Inc.
AOTI, Inc., founded in 2006 and based in Oceanside, California, and Galway, Ireland, is a medical technology company specializing in innovative solutions for severe and chronic wound care. The company focuses on reducing healthcare costs and improving patient quality of life through its patented non-invasive Topical Wound Oxygen (TWO2®) therapy, which has shown significant efficacy in reducing diabetic foot ulcer recurrence, hospitalizations, and amputations.
YTD Price Performance: -25.68%
Average Trading Volume: 33,218
Technical Sentiment Signal: Strong Buy
Current Market Cap: £87.75M
For an in-depth examination of AOTI stock, go to TipRanks’ Stock Analysis page.